Your browser doesn't support javascript.
loading
Factors Affecting Sentinel Node Metastasis in Thin (T1) Cutaneous Melanomas: Development and External Validation of a Predictive Nomogram.
Maurichi, Andrea; Miceli, Rosalba; Eriksson, Hanna; Newton-Bishop, Julia; Nsengimana, Jérémie; Chan, May; Hayes, Andrew J; Heelan, Kara; Adams, David; Patuzzo, Roberto; Barretta, Francesco; Gallino, Gianfranco; Harwood, Catherine; Bergamaschi, Daniele; Bennett, Dorothy; Lasithiotakis, Konstantinos; Ghiorzo, Paola; Dalmasso, Bruna; Manganoni, Ausilia; Consoli, Francesca; Mattavelli, Ilaria; Barbieri, Consuelo; Leva, Andrea; Cortinovis, Umberto; Espeli, Vittoria; Mangas, Cristina; Quaglino, Pietro; Ribero, Simone; Broganelli, Paolo; Pellacani, Giovanni; Longo, Caterina; Del Forno, Corrado; Borgognoni, Lorenzo; Sestini, Serena; Pimpinelli, Nicola; Fortunato, Sara; Chiarugi, Alessandra; Nardini, Paolo; Morittu, Elena; Florita, Antonio; Cossa, Mara; Valeri, Barbara; Milione, Massimo; Pruneri, Giancarlo; Zoras, Odysseas; Anichini, Andrea; Mortarini, Roberta; Santinami, Mario.
Afiliación
  • Maurichi A; Melanoma and Sarcoma Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori di Milano, Milan, Italy.
  • Miceli R; Medical Statistics, Biometry and Bioinformatics Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
  • Eriksson H; Department of Oncology, Theme Cancer, Karolinska University Hospital, Stockholm, Sweden.
  • Newton-Bishop J; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Nsengimana J; Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, United Kingdom.
  • Chan M; Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, United Kingdom.
  • Hayes AJ; Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, United Kingdom.
  • Heelan K; Sarcoma Unit, Royal Marsden National Health Service (NHS) Foundation Trust, London, United Kingdom.
  • Adams D; Skin Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Patuzzo R; Sarcoma Unit, Royal Marsden National Health Service (NHS) Foundation Trust, London, United Kingdom.
  • Barretta F; Skin Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Gallino G; Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, United Kingdom.
  • Harwood C; Melanoma and Sarcoma Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori di Milano, Milan, Italy.
  • Bergamaschi D; Medical Statistics, Biometry and Bioinformatics Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
  • Bennett D; Melanoma and Sarcoma Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori di Milano, Milan, Italy.
  • Lasithiotakis K; Queen Mary University of London, London, United Kingdom.
  • Ghiorzo P; Queen Mary University of London, London, United Kingdom.
  • Dalmasso B; Molecular and Clinical Sciences Research Institute, St George's, University of London, London, United Kingdom.
  • Manganoni A; York Teaching Hospital NHS Foundation Trust, York, United Kingdom.
  • Consoli F; Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
  • Mattavelli I; University Hospital of Genoa, Genoa, Italy.
  • Barbieri C; University Hospital of Genoa, Genoa, Italy.
  • Leva A; University Hospital of Brescia, Brescia, Italy.
  • Cortinovis U; University Hospital of Brescia, Brescia, Italy.
  • Espeli V; Melanoma and Sarcoma Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori di Milano, Milan, Italy.
  • Mangas C; Melanoma and Sarcoma Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori di Milano, Milan, Italy.
  • Quaglino P; Melanoma and Sarcoma Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori di Milano, Milan, Italy.
  • Ribero S; Plastic and Reconstructive Surgical Unit, Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
  • Broganelli P; Istituto Oncologico Svizzera Italiana, Ospedale Regionale Bellinzona e Valli, Bellinzona, Switzerland.
  • Pellacani G; Istituto Oncologico Svizzera Italiana, Ospedale Regionale Bellinzona e Valli, Bellinzona, Switzerland.
  • Longo C; University Hospital of Turin, Turin, Italy.
  • Del Forno C; University Hospital of Turin, Turin, Italy.
  • Borgognoni L; University Hospital of Turin, Turin, Italy.
  • Sestini S; University Hospital of Modena, Modena, Italy.
  • Pimpinelli N; Department of Dermatology, University of Modena and Reggio Emilia, Modena, Italy.
  • Fortunato S; Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia, Centro Oncologico ad Alta Tecnologia Diagnostica-Dermatologia, Reggio Emilia, Italy.
  • Chiarugi A; University Hospital of Pavia, Pavia, Italy.
  • Nardini P; Ospedale S. Maria Annunziata, Tuscan Cancer Institute, Florence, Italy.
  • Morittu E; Ospedale S. Maria Annunziata, Tuscan Cancer Institute, Florence, Italy.
  • Florita A; Division of Dermatology, University of Florence, Florence, Italy.
  • Cossa M; Division of Dermatology, University of Florence, Florence, Italy.
  • Valeri B; Institute for Cancer Research and Prevention, Florence, Italy.
  • Milione M; Institute for Cancer Research and Prevention, Florence, Italy.
  • Pruneri G; Scientific Directorate, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
  • Zoras O; Scientific Directorate, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
  • Anichini A; Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
  • Mortarini R; Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
  • Santinami M; Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
J Clin Oncol ; 38(14): 1591-1601, 2020 05 10.
Article en En | MEDLINE | ID: mdl-32167862
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: J Clin Oncol Año: 2020 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: J Clin Oncol Año: 2020 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Estados Unidos